Feldan Therapeutics

Series-B+
feldan.com Biotech & Healthcare
Total Funding $29M
Latest Round Undisclosed Series-B+
Last Announced Sep 4, 2024
Investors Undisclosed
Decision Makers 6 Verified

About Feldan Therapeutics

Creating better futures for patients, Feldan drives deep science and therapeutic innovation by enabling the intracellular delivery of ASO.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website feldan.com
Domain Registered Date Nov 19, 2005

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-B+ announced

    startupintros.com

  2. Capital Raise

    Raised $16,500,000 · Series-B+

    startupintros.com

  3. Capital Raise

    Raised $12,500,000 · Series-A

    startupintros.com

  4. Milestone

    Website domain registered

    feldan.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Feldan Therapeutics.

Funding History

3 Rounds
Series-B+ · Sep 4, 2024
Series-B+ · Jun 13, 2023
Series-A · Sep 18, 2018

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts